RYTVELA TFA
RYTVELA TFA (H-Arg-Tyr-Thr-Val-Glu-Leu-Ala-OH) is a non-competitive metabotropic interleukin-1 receptor inhibitor with anti-inflammatory properties. Its application in research includes investigating the mechanisms of preterm labor, with studies exploring its role in inhibiting inflammation-driven uterine activation in both cellular and animal models.
Product Specifications
Field of Research
Immunology & Inflammation
Molecular Weight
850.96
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GBC62481-01 50 mg
1- (3-Cyano-6-methylpyridin-2-yl) piperidine-3-carboxylic acid
Sign In for Pricing
View Details GBC62481-02 0.5 g
1- (3-Cyano-6-methylpyridin-2-yl) piperidine-3-carboxylic acid
Sign In for Pricing
View Details 
K1999806 1.0 µg DNA
RPS2P8 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 